BR1100834A - Piridopirimidinas substituìdas e antihipertensivos - Google Patents

Piridopirimidinas substituìdas e antihipertensivos

Info

Publication number
BR1100834A
BR1100834A BR1100834-2A BR1100834A BR1100834A BR 1100834 A BR1100834 A BR 1100834A BR 1100834 A BR1100834 A BR 1100834A BR 1100834 A BR1100834 A BR 1100834A
Authority
BR
Brazil
Prior art keywords
pyridopyrimidines
antihypertensive
substituted
antihypertensive pyridopyrimidines
Prior art date
Application number
BR1100834-2A
Other languages
English (en)
Inventor
John Watson Ellingboe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to BR1100834-2A priority Critical patent/BR1100834A/pt
Publication of BR1100834A publication Critical patent/BR1100834A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR1100834-2A 1993-03-24 1997-05-12 Piridopirimidinas substituìdas e antihipertensivos BR1100834A (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR1100834-2A BR1100834A (pt) 1993-03-24 1997-05-12 Piridopirimidinas substituìdas e antihipertensivos

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3661593A 1993-03-24 1993-03-24
BR1100834-2A BR1100834A (pt) 1993-03-24 1997-05-12 Piridopirimidinas substituìdas e antihipertensivos

Publications (1)

Publication Number Publication Date
BR1100834A true BR1100834A (pt) 2000-06-06

Family

ID=21889617

Family Applications (1)

Application Number Title Priority Date Filing Date
BR1100834-2A BR1100834A (pt) 1993-03-24 1997-05-12 Piridopirimidinas substituìdas e antihipertensivos

Country Status (6)

Country Link
US (1) US5466692A (pt)
KR (1) KR100251822B1 (pt)
BR (1) BR1100834A (pt)
CO (1) CO4230097A1 (pt)
TW (1) TW321648B (pt)
ZA (1) ZA941897B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2223783A1 (en) * 1995-06-07 1996-12-19 Michel Bernatchez Process for preparation of biphenyl derivatives
US5760220A (en) * 1995-06-07 1998-06-02 American Home Products Corporation Process for preparation of biphenyl derivatives
US7235551B2 (en) * 2000-03-02 2007-06-26 Smithkline Beecham Corporation 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
EP2404603A1 (en) 2000-10-23 2012-01-11 Glaxosmithkline LLC Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds for the treatment of CSBP/p38 kinase mediated diseases
CN1503797A (zh) * 2001-02-26 2004-06-09 田边制药株式会社 吡啶并嘧啶或二氮杂萘衍生物
ATE370952T1 (de) * 2002-04-19 2007-09-15 Smithkline Beecham Corp Neue verbindungen
PE20100737A1 (es) 2005-03-25 2010-11-27 Glaxo Group Ltd Nuevos compuestos
US7479558B2 (en) * 2005-03-25 2009-01-20 Glaxo Group Limited Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives
AR053450A1 (es) * 2005-03-25 2007-05-09 Glaxo Group Ltd Derivados de 3,4-dihidro-pirimido(4,5-d)pirimidin-2-(1h)-ona 1,5,7 trisustituidos como inhibidores de la quinasa p38
US20090137550A1 (en) * 2005-03-25 2009-05-28 Glaxo Group Limited Novel Compounds
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
US11066404B2 (en) 2018-10-11 2021-07-20 Incyte Corporation Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
US11384083B2 (en) 2019-02-15 2022-07-12 Incyte Corporation Substituted spiro[cyclopropane-1,5′-pyrrolo[2,3-d]pyrimidin]-6′(7′h)-ones as CDK2 inhibitors
WO2020180959A1 (en) 2019-03-05 2020-09-10 Incyte Corporation Pyrazolyl pyrimidinylamine compounds as cdk2 inhibitors
WO2020205560A1 (en) 2019-03-29 2020-10-08 Incyte Corporation Sulfonylamide compounds as cdk2 inhibitors
US11447494B2 (en) 2019-05-01 2022-09-20 Incyte Corporation Tricyclic amine compounds as CDK2 inhibitors
WO2020223469A1 (en) 2019-05-01 2020-11-05 Incyte Corporation N-(1-(methylsulfonyl)piperidin-4-yl)-4,5-di hydro-1h-imidazo[4,5-h]quinazolin-8-amine derivatives and related compounds as cyclin-dependent kinase 2 (cdk2) inhibitors for treating cancer
TW202115024A (zh) 2019-08-14 2021-04-16 美商英塞特公司 作為cdk2 抑制劑之咪唑基嘧啶基胺化合物
KR20220099970A (ko) 2019-10-11 2022-07-14 인사이트 코포레이션 Cdk2 억제제로서의 이환식 아민
US11981671B2 (en) 2021-06-21 2024-05-14 Incyte Corporation Bicyclic pyrazolyl amines as CDK2 inhibitors
US11976073B2 (en) 2021-12-10 2024-05-07 Incyte Corporation Bicyclic amines as CDK2 inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0481614A1 (en) * 1990-10-01 1992-04-22 Merck & Co. Inc. Substituted pyridopyrimidinones and related heterocycles as angiotensin II antagonists
IL100917A0 (en) * 1991-02-16 1992-11-15 Fisons Plc Pyridinone and pyrimidinone derivatives,their preparation and pharmaceutical compositions containing them
AU1625192A (en) * 1991-05-31 1992-12-03 Zeneca Limited Heterocyclic derivatives
US5149699A (en) * 1991-10-24 1992-09-22 American Home Products Corporation Substituted pyridopyrimidines useful as antgiotensin II antagonists
US5281602A (en) * 1993-04-23 1994-01-25 American Cyanamid Company Angiotensin II receptor blocking 2,3,6-substituted 5,6,7,8-tetrahydro-pyrido[4,3-D]pyrimidin-4(3H)-ones
US5296480A (en) * 1993-04-23 1994-03-22 American Cyanamid Company Angiotensin II receptor blocking 2,3,6-substituted 5,6,7,8-tetra-hydro-pyrido[4,3]pyrimidin-4(3H)-ones

Also Published As

Publication number Publication date
KR100251822B1 (ko) 2000-09-01
US5466692A (en) 1995-11-14
KR940021553A (ko) 1994-10-19
ZA941897B (en) 1995-09-18
TW321648B (pt) 1997-12-01
CO4230097A1 (es) 1995-10-19

Similar Documents

Publication Publication Date Title
FI932615A0 (fi) Anordning foer minimering av virvelstroemmar i en magnetisk avbildningsapparat foersedd med polskor
BR1100834A (pt) Piridopirimidinas substituìdas e antihipertensivos
FI944624A (fi) 4-aryyliaminobentsopyraani- ja niiden kaltaisia yhdisteitä
FI933331A0 (fi) Foerfarande foer behandling av vattenloeslig naeringsfiber med beta-glukanas
BR9407273A (pt) Conbinação detergente-embalagem
ITMI921571A1 (it) Azaciclo e azabiciclo alchiliden idrossilamine
NO930418D0 (no) Innstikkbar helletut
FI1313U1 (fi) Stolpsko med svaengbar skaera
ITMI931648A1 (it) Azaciclo e azabiciclo ammidi
FIU930624U0 (fi) Ja/nej-svarkuvert
FI1063U1 (fi) Gungbraeda med flera frihetsgrader
FI815U1 (fi) Med bakgrind foersedd utfodringsautomat foer mjoelkkor
FI1680U1 (fi) Saeng med stoedanordning
FI1388U1 (fi) Saeng med stoedanordning
FI1301U1 (fi) Handtvaettmaskin med straole foer baotar
FI1300U1 (fi) Handtvaettmaskin med borste foer baotar
FI1223U1 (fi) Med vallning foersedd skida
FI1177U1 (fi) Trosor med aoteranvaendbart skydd
FI934580A0 (fi) Kassaskrin med tillhoerande laosningssystem och -foerfarnade
FIU930594U0 (fi) Med vinsch foersedd baotrupphissningskaerra
FI934038A0 (fi) Affischreklamstaell foersett med nyheter
FI934376A0 (fi) Spatel med tillhoerande spetsdel
FI931984A0 (fi) Plastprodukt med fyllmedel
FI934769A0 (fi) Lastutrymme med foeraenderlig volym
FI935629A0 (fi) Braedspel med ishockeymotiv

Legal Events

Date Code Title Description
AN Processing applications according to articles 230 and 231 of law 9279/96: notification of filing an application
HHFK Processing applications according to articles 230 and 231 of law 9.279/96: republication
MT Patent procedure suspended until requirement met - articles 230 and 231 of law 9279/96
FGAN Processing applications according to articles 230 and 231 of law 9.279/96: granting
NB Patent issued - articles 230 and 231 of law 9279/96
B25D Requested change of name of applicant approved